FDA issues drug injury alert on Tussionex
March 18, 2008
The United States Food and Drug Administration has issued an alert on Tussionex Pennkinetic Extended Release Suspension due to recent reports of drug injuries, including death, as a result of misuse and inappropriate use of the prescription cough medicine.
Risk of drug injury is associated with patients who may be taking more Tussionex, or doctors who may be prescribing more Tussionex than is recommended or prescribing Tussionex more frequently than every 12 hours.
Children under 6 years old who take Tussionex against recommendations could also be at risk of drug injury
Misuse and inappropriate use of Tussionex could also cause Texas drug injuries.